Bromberg J, Issa S, Bukanina K, et al. Effect of Rituximab in Primary Central Nervous System Lymphoma – results of the Randomized Phase III HOVON 105/ALLG NHL 24 Study. ASH 59th Annual Meeting & Exhibition, abstract 582.
Veilig stoppen met ibrutinib en venetoclax bij minimale restziekte CLL
jun 2022 | Leukemie